KLK4 and ovarian carcinoma: They have developed methods to quantify all kallikrein proteins in serum and tissue extracts and have identified six kallikreins with prognostic value that are specifically over-expressed in ovarian cancer (KLK5, KLK6, KLK8, KLK10, KLK11, KLK13).